Summit Mission Statement To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, and successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy* intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs. To identify and control promising product candidates based on exceptional scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner, and to engage commercialization and/or development partners when appropriate. We accomplish this by building a team of world class professional scientists and business administrators that apply their experience and knowledge to this mission. Team Summit exists to pose, strategize, and execute a path forward in medicinal therapeutic health care that places Summit in a well-deserved, top market share, leadership position. Team Summit assumes full responsibility for stimulating continuous expansion of knowledge, ability, capability, and well-being for all involved stakeholders and highly-valued shareholders. Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK and Cambridge, UK. *For our purposes, friendly medicinal therapy is defined as follows: therapeutic efficacy (cure with duration and without recurrence and resistance) over therapeutic trauma. Therapeutic trauma is defined as serious side effects while on therapy or post-therapy but related to therapy, disease recurrence, patient non–compliance with daily dosage due to challenges associated with our therapy, its affordability, or accessibility.
View Top Employees from Summit TherapeuticsWebsite | https://www.smmttx.com/ |
Ticker | SMMT |
Revenue | $54 million |
Funding | $34.2 million |
Employees | 93 (47 on RocketReach) |
Founded | 2003 |
Address | 2882 Sand Hill Rd, Menlo Park, California 94025, US |
Phone | +44 1235 443939 |
Industry | Biotechnology, Drug Manufacturing & Research, Biopharmaceuticals, Pharmaceuticals, Science and Engineering, Drug Discovery, Duchenne muscular dystrophy, Healthcare, Medical Device, C. difficile infection, Health Care, Drug development, Therapeutics |
Web Rank | 3 Million |
Keywords | Summit Therapeutics, Summit (Cambridge) Limited, Summit Therapeutics Uk, Summit Uk Press Contact, Summit Therapeutics Salary |
Competitors | 4Sc Ag, Affectis Pharmaceuticals, Anavex Life Sciences, Aptahem, ManRos Therapeutics |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Summit Therapeutics employee's phone or email?
The Summit Therapeutics annual revenue was $54 million in 2023.
Maky Zanganeh is the COO of Summit Therapeutics.
47 people are employed at Summit Therapeutics.
Summit Therapeutics is based in Menlo Park, California.
The NAICS codes for Summit Therapeutics are [32, 3254, 32541, 325].
The SIC codes for Summit Therapeutics are [283, 28].